NASDAQ:VERU Veru (VERU) News Today $1.01 +0.02 (+2.02%) (As of 10:40 AM ET) Add Compare Share Share Today's Range$0.96▼$1.0250-Day Range$0.99▼$1.4952-Week Range$0.93▼$24.55Volume871,674 shsAverage Volume2.53 million shsMarket Capitalization$90.13 millionP/E RatioN/ADividend YieldN/APrice Target$13.67 HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Get Veru News Delivered to You Automatically Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter. Email Address VERU Media Mentions By Week VERU Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VERU News Sentiment▼0.000.66▲Average Medical News Sentiment VERU News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VERU Articles This Week▼05▲VERU Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineVeru Announces Appointment of Dr. Erik Swenson and Dr. Robert Schooley to its Infectious Disease Scientific Advisory Boardfinance.yahoo.com - June 1 at 9:53 AMVeru to Present at the Jefferies Healthcare Conferencefinance.yahoo.com - May 24 at 8:58 AMHC Wainwright Equities Analysts Decrease Earnings Estimates for Veru Inc. (NASDAQ:VERU)americanbankingnews.com - May 20 at 2:58 AMHC Wainwright & Co. Maintains Veru (VERU) Buy Recommendationmsn.com - May 15 at 4:58 PMH.C. Wainwright Sticks to Its Buy Rating for Veru (VERU)markets.businessinsider.com - May 15 at 8:36 AMVeru (NASDAQ:VERU) PT Lowered to $2.00americanbankingnews.com - May 15 at 7:56 AMVeru Inc.: Veru Reports Fiscal 2023 Second Quarter Financial Resultsfinanznachrichten.de - May 12 at 8:49 PMVeru Q2: Revenue Halves, Prioritizes Clinical Programs, Wider Loss & Moremsn.com - May 12 at 10:49 AMVeru Inc. (VERU) Reports Q2 Loss, Tops Revenue Estimatesfinance.yahoo.com - May 11 at 1:35 PMVeru: Q2 Earnings Insightsmsn.com - May 11 at 8:34 AMVERU Stock Earnings: Veru Misses EPS, Beats Revenue Estimatesmarkets.businessinsider.com - May 11 at 8:34 AMVeru Reports Fiscal 2023 Second Quarter Financial Resultsfinance.yahoo.com - May 11 at 8:34 AMAnalyst Ratings for Verumarkets.businessinsider.com - May 10 at 3:55 PMA Preview Of Veru's Earningsmsn.com - May 10 at 3:55 PMVeru Q2 2023 Earnings Previewmsn.com - May 10 at 3:55 PMIs a Surprise Coming for Veru (VERU) This Earnings Season?finance.yahoo.com - May 9 at 3:10 PMVeru (VERU) Set to Announce Quarterly Earnings on Thursdayamericanbankingnews.com - May 9 at 4:34 AMVeru Reaches Agreement with FDA on Confirmatory Phase 3 Clinical Trial for Sabizabulin Treatment of Hospitalized COVID-19 Adult Patients at High Risk for ARDSfinance.yahoo.com - May 4 at 1:26 PMVeru Inc. (VERU) Expected to Beat Earnings Estimates: Can the Stock Move Higher?finance.yahoo.com - May 4 at 1:26 PMVeru (VERU) to Release Quarterly Earnings on Thursdaymarketbeat.com - May 4 at 2:25 AMVeru Enters into Common Stock Purchase Agreement for Up to $100 Million with Lincoln Park Capitalfinance.yahoo.com - May 3 at 10:58 AMQ2 2023 Earnings Estimate for Veru Inc. (NASDAQ:VERU) Issued By HC Wainwrightamericanbankingnews.com - April 30 at 1:44 AMVeru Inc. (NASDAQ:VERU) Receives Consensus Rating of "Buy" from Analystsamericanbankingnews.com - April 29 at 5:08 AMVeru Inc. (NASDAQ:VERU) Short Interest Updatemarketbeat.com - April 28 at 9:50 AMQ2 2023 EPS Estimates for Veru Inc. Reduced by HC Wainwright (NASDAQ:VERU)marketbeat.com - April 28 at 6:40 AMVeru to Report Fiscal 2023 Second Quarter Financial Results on May 11, 2023finance.yahoo.com - April 27 at 9:44 AMVeru Sells ENTADFI® Business for $20 Million Plus up to an Additional $80 Million from Sales Milestonesfinance.yahoo.com - April 20 at 9:08 AMVeru Enters Into Supply Agreement with Afaxys to Expand Access to FC2 Female Condom® in U.S. Public Health Sectorfinance.yahoo.com - April 19 at 1:28 PMVeru (NASDAQ:VERU) Receives Buy Rating from HC Wainwrightamericanbankingnews.com - April 15 at 3:16 AMThe Latest Analyst Ratings for Verumarkets.businessinsider.com - April 13 at 4:38 PMHC Wainwright & Co. Reiterates Veru (VERU) Buy Recommendationmsn.com - April 13 at 4:38 PMDown -51.21% in 4 Weeks, Here's Why You Should You Buy the Dip in Veru Inc. (VERU)finance.yahoo.com - April 12 at 1:37 PMOnce COVID-19 Candidate, Veru's Sabizabulin Shows Encouraging Action In Animal Studies Against Poxvirusfinance.yahoo.com - April 11 at 8:32 PMVeru Announces Preclinical Study Results that Demonstrate Sabizabulin Inhibits Poxvirusesfinance.yahoo.com - April 11 at 10:31 AMVeru (NASDAQ:VERU) Given New $6.00 Price Target at HC Wainwrightamericanbankingnews.com - April 7 at 7:28 AMVeru Inc. (NASDAQ:VERU) Receives $28.33 Average Target Price from Analystsamericanbankingnews.com - April 7 at 3:30 AMVeru Announces Preclinical Results from Expanded Sabizabulin Program into Influenza-Induced Severe Acute Respiratory Distress Syndrome and Provides Update on COVID-19 Programfinance.yahoo.com - April 4 at 1:31 PMVeru Inc.'s (NASDAQ:VERU) recent 20% pullback adds to one-year year losses, institutional owners may take drastic measuresfinance.yahoo.com - March 27 at 8:25 AMOppenheimer Weighs in on Veru Inc.'s Q2 2023 Earnings (NASDAQ:VERU)marketbeat.com - March 17 at 6:20 AMUPDATE 1-Veru to proceed with late-stage study of COVID pill despite FDA snubfinance.yahoo.com - March 14 at 5:52 PM407,139 Shares in Veru Inc. (NASDAQ:VERU) Acquired by Renaissance Technologies LLCmarketbeat.com - March 13 at 4:35 AMVeru Inc. (NASDAQ:VERU) Given Consensus Recommendation of "Buy" by Brokeragesmarketbeat.com - March 10 at 4:43 AMVeru to Present at the Oppenheimer 33rd Annual Healthcare Conferencefinance.yahoo.com - March 7 at 9:18 AMWhy Is Veru (VERU) Stock Down 37% Today?investorplace.com - March 3 at 11:00 AMVeru Provides FDA Update on Request for Emergency Use Authorization for Sabizabulin for Hospitalized COVID-19 Patients at High Risk for ARDSfinance.yahoo.com - March 2 at 6:59 PMVeru Inc. (NASDAQ:VERU) Shares Could Be 50% Below Their Intrinsic Value Estimatefinance.yahoo.com - February 14 at 10:09 AMVeru Inc. (NASDAQ:VERU) Expected to Post Q1 2024 Earnings of ($0.13) Per Sharemarketbeat.com - February 13 at 3:06 AMVeru Inc. (NASDAQ:VERU) Q1 2023 Earnings Call Transcriptfinance.yahoo.com - February 10 at 8:09 PMVeru (NASDAQ:VERU) Price Target Cut to $14.00 by Analysts at HC Wainwrightmarketbeat.com - February 10 at 8:38 AMFinal Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Veru Inc. (VERU) Investors of Class Action and to Actively Participatebenzinga.com - February 7 at 4:38 AM Get Veru News Delivered to You Automatically Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NATR News VACC News HOWL News SPRB News INCR News LPTX News RNAZ News BCTX News RLMD News ETON News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:VERU) was last updated on 6/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veru Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.